Kazianka, L <br/><br/>
Ristocetin-induced platelet aggregation for monitoring of bleeding tendency in CLL treated with ibrutinib.  [electronic resource] 

 -  Leukemia  05 2017 
 - 1117-1122 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study 
<br/><br/><label>ISSN: </label>1476-5551 
<br/><br/><label>Standard No.: </label>10.1038/leu.2016.316  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenine--analogs & derivatives<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Drug Monitoring--methods<br/>Female<br/>Hemorrhage--chemically induced<br/>Humans<br/>Leukemia, Lymphocytic, Chronic, B-Cell--complications<br/>Male<br/>Middle Aged<br/>Piperidines<br/>Platelet Aggregation--drug effects<br/>Protein Kinase Inhibitors--adverse effects<br/>Pyrazoles--administration & dosage<br/>Pyrimidines--administration & dosage<br/>Ristocetin--pharmacology